{"url":"https://lda.senate.gov/api/v1/filings/e4eb977c-e464-4053-a248-e1916bd88507/","filing_uuid":"e4eb977c-e464-4053-a248-e1916bd88507","filing_type":"1T","filing_type_display":"1st Quarter - Termination","filing_year":2021,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/e4eb977c-e464-4053-a248-e1916bd88507/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"David J. Farber, Partner","dt_posted":"2021-04-19T11:17:16.977000-04:00","termination_date":"2021-03-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1700 Pennsylvania Avenue, NW, Suite 200","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":21632,"url":"https://lda.senate.gov/api/v1/registrants/21632/","house_registrant_id":30750,"name":"KING & SPALDING LLP","description":"Law firm","address_1":"1700 Pennsylvania Avenue NW","address_2":"Suite 900","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"THOMAS J. SPULAK","contact_telephone":"+1 202-737-0500","dt_updated":"2026-07-30T11:37:36.821819-04:00"},"client":{"id":128511,"url":"https://lda.senate.gov/api/v1/clients/128511/","client_id":1005914,"name":"AUDENTES THERAPEUTICS","general_description":"Biotechnology company","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-09-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocacy related to value-based payments for regenerative medicines","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41569,"prefix":null,"prefix_display":null,"first_name":"ALLISON","nickname":null,"middle_name":"F","last_name":"KASSIR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143042,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"JOSEPH","last_name":"FARBER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}